2026
A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemiaLeukemia, Acute Lymphoblastic Leukemia research
Active, last published 2026
In acute lymphoblastic leukemia research
Sara M.A.
Mohamed
Scholar“Research focused on Acute Lymphoblastic Leukemia research and adjacent fields.”
Ain Shams UniversityEgypt
Claim Your Profile3
H-index
13
Citations
Sara has not officially claimed their profile. If you are Sara, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
ara M.A. Mohamed is a researcher working on Acute Lymphoblastic Leukemia research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sara's work has been cited 13 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Acute Lymphoblastic Leukemia research×5CAR-T cell therapy research×3Immune Cell Function and Interaction×2Chronic Myeloid Leukemia Treatments×2Acute Myeloid Leukemia Research×1
06 · Where I am
Affiliations
CurrentlyAin Shams University, Egypt
Research themes (UN SDGs)
07 · Selected work
Recent publications
Are you Sara?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required